Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
D DERMATOLOGICALS
D05 ANTIPSORIATICS
D05A ANTIPSORIATICS FOR TOPICAL USE
D05AX Other antipsoriatics for topical use
D05AX06 Roflumilast
D05744 Roflumilast (JAN/USAN/INN) <US>
R RESPIRATORY SYSTEM
R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
R03D OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
R03DX Other systemic drugs for obstructive airway diseases
R03DX07 Roflumilast
D05744 Roflumilast (JAN/USAN/INN) <US>
USP drug classification [BR:br08302]
Respiratory Tract/Pulmonary Agents
Phosphodiesterase Inhibitors, Airways Disease
Roflumilast
D05744 Roflumilast (JAN/USAN/INN)
Drug groups [BR:br08330]
Metabolizing enzyme substrate
DG01892 CYP1A2 substrate
D05744 Roflumilast
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
D05744 Roflumilast
Target-based classification of drugs [BR:br08310]
Enzymes
Hydrolases (EC3)
Phosphodiesterases
PDE4
D05744 Roflumilast (JAN/USAN/INN) <US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D05744
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D05744
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D05744
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D05744